These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 16787359)
1. Current status of virtual screening as analysed by target class. Stoermer MJ Med Chem; 2006 Jan; 2(1):89-112. PubMed ID: 16787359 [TBL] [Abstract][Full Text] [Related]
3. Synergies of virtual screening approaches. Muegge I Mini Rev Med Chem; 2008 Aug; 8(9):927-33. PubMed ID: 18691150 [TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of protein superfamily-targeted chemical libraries for lead identification and optimization. Shuttleworth SJ; Connors RV; Fu J; Liu J; Lizarzaburu ME; Qiu W; Sharma R; Wãnska M; Zhang AJ Curr Med Chem; 2005; 12(11):1239-81. PubMed ID: 15974996 [TBL] [Abstract][Full Text] [Related]
5. Using silico methods predicting ligands for orphan GPCRs. Jiang Z; Zhou Y Curr Protein Pept Sci; 2006 Oct; 7(5):459-64. PubMed ID: 17073696 [TBL] [Abstract][Full Text] [Related]
6. The physicochemical challenges of designing multiple ligands. Morphy R; Rankovic Z J Med Chem; 2006 Aug; 49(16):4961-70. PubMed ID: 16884308 [TBL] [Abstract][Full Text] [Related]
7. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors. Park H; Li M; Choi J; Cho H; Ham SW Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977 [TBL] [Abstract][Full Text] [Related]
8. Recent development and application of virtual screening in drug discovery: an overview. Hou T; Xu X Curr Pharm Des; 2004; 10(9):1011-33. PubMed ID: 15078130 [TBL] [Abstract][Full Text] [Related]
9. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands. Bermudez M; Wolber G Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056 [TBL] [Abstract][Full Text] [Related]
11. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors. Rodríguez D; Gutiérrez-de-Terán H Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842 [TBL] [Abstract][Full Text] [Related]
12. Enhancing drug discovery through in silico screening: strategies to increase true positives retrieval rates. Kirchmair J; Distinto S; Schuster D; Spitzer G; Langer T; Wolber G Curr Med Chem; 2008; 15(20):2040-53. PubMed ID: 18691055 [TBL] [Abstract][Full Text] [Related]
13. Virtual screening in drug discovery -- a computational perspective. Reddy AS; Pati SP; Kumar PP; Pradeep HN; Sastry GN Curr Protein Pept Sci; 2007 Aug; 8(4):329-51. PubMed ID: 17696867 [TBL] [Abstract][Full Text] [Related]
14. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening. Tanrikulu Y; Schneider G Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of virtual screening as a tool for chemical genetic applications. Campagna-Slater V; Schapira M J Chem Inf Model; 2009 Sep; 49(9):2082-91. PubMed ID: 19702241 [TBL] [Abstract][Full Text] [Related]
16. Virtual screening in lead discovery and optimization. Jain AN Curr Opin Drug Discov Devel; 2004 Jul; 7(4):396-403. PubMed ID: 15338948 [TBL] [Abstract][Full Text] [Related]
17. Docking and Virtual Screening Strategies for GPCR Drug Discovery. Beuming T; Lenselink B; Pala D; McRobb F; Repasky M; Sherman W Methods Mol Biol; 2015; 1335():251-76. PubMed ID: 26260606 [TBL] [Abstract][Full Text] [Related]